Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: GlobalData
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Thermo Fisher Scientific Inc issues FY 2014 guidance

Thursday, 30 Jan 2014 06:00am EST 

Thermo Fisher Scientific Inc:Expects to achieve FY 2014 adjusted EPS in the range of $6.70 to $6.90, which would result in 24 pct to 27 pct adjusted EPS growth over FY 2013.Expects to achieve FY 2014 revenue in the range of $16.63 bln to $16.83 bln, for 27 pct to 29 pct revenue growth year over year.Says FY 2014 guidance includes the results of Life Technologies from an assumed close date, and includes the results of the previously announced divestitures through an assumed sale date.Says the guidance does not include any other future acquisitions or divestitures and is based on current foreign exchange rates.Says the adjusted EPS estimate excludes amortization expense for acquisition-related intangible assets. 

Company Quote

0.22 +0.17%
10:22am EST